Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132]

Name Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132]
Supplier Abcam
Catalog ab32101
Prices $394.00
Sizes 100 µl
Host Rabbit
Clonality Monoclonal
Isotype IgG
Clone E132
Applications WB IHC-F IHC-P ICC/IF IP DB
Species Reactivities Mouse, Rat, Human
Antigen Synthetic phosphopeptide corresponding to residues surrounding Tyr 1007 and Tyr 1008 of human JAK2
Description Rabbit Monoclonal
Gene JAK2
Conjugate Unconjugated
Supplier Page Shop

Product images


Product References

Inhibition of casein kinase II reduces TGFbeta induced fibroblast activation and - Inhibition of casein kinase II reduces TGFbeta induced fibroblast activation and

Zhang Y, Dees C, Beyer C, Lin NY, Distler A, Zerr P, Palumbo K, Susok L, Kreuter A, Distler O, Schett G, Distler JH. Ann Rheum Dis. 2015 May;74(5):936-43.

Multimeric growth hormone receptor complexes serve as signaling platforms. - Multimeric growth hormone receptor complexes serve as signaling platforms.

Sedek M, van der Velden LM, Strous GJ. J Biol Chem. 2014 Jan 3;289(1):65-73.

Epigallocatechin-3-gallate ameliorates seawater aspiration-induced acute lung - Epigallocatechin-3-gallate ameliorates seawater aspiration-induced acute lung

Liu W, Dong M, Bo L, Li C, Liu Q, Li Y, Ma L, Xie Y, Fu E, Mu D, Pan L, Jin F, Li Z. Mediators Inflamm. 2014;2014:612593.

JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the - JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the

Gallipoli P, Cook A, Rhodes S, Hopcroft L, Wheadon H, Whetton AD, Jorgensen HG, Bhatia R, Holyoake TL. Blood. 2014 Aug 28;124(9):1492-501.

Dual PI3K/AKT/mTOR inhibitor BEZ235 synergistically enhances the activity of JAK2 - Dual PI3K/AKT/mTOR inhibitor BEZ235 synergistically enhances the activity of JAK2

Fiskus W, Verstovsek S, Manshouri T, Smith JE, Peth K, Abhyankar S, McGuirk J, Bhalla KN. Mol Cancer Ther. 2013 May;12(5):577-88.

Gene expression profiling for analysis acquired oxaliplatin resistant factors in - Gene expression profiling for analysis acquired oxaliplatin resistant factors in

Chen CC, Chu CB, Liu KJ, Huang CY, Chang JY, Pan WY, Chen HH, Cheng YH, Lee KD, Chen MF, Kuo CC, Chen LT. Biochem Pharmacol. 2013 Oct 1;86(7):872-87.

PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid - PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid

Neviani P, Harb JG, Oaks JJ, Santhanam R, Walker CJ, Ellis JJ, Ferenchak G, Dorrance AM, Paisie CA, Eiring AM, Ma Y, Mao HC, Zhang B, Wunderlich M, May PC, Sun C, Saddoughi SA, Bielawski J, Blum W, Klisovic RB, Solt JA, Byrd JC, Volinia S, Cortes J, Huettner CS, Koschmieder S, Holyoake TL, Devine S, Caligiuri MA, Croce CM, Garzon R, Ogretmen B, Arlinghaus RB, Chen CS, Bittman R, Hokland P, Roy DC, Milojkovic D, Apperley J, Goldman JM, Reid A, Mulloy JC, Bhatia R, Marcucci G, Perrotti D. J Clin Invest. 2013 Oct;123(10):4144-57.

A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion - A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion

Bao W, Wang HH, Tian FJ, He XY, Qiu MT, Wang JY, Zhang HJ, Wang LH, Wan XP. Mol Cancer. 2013 Dec 9;12:155.

A dynamic real time in vivo and static ex vivo analysis of granulomonocytic cell - A dynamic real time in vivo and static ex vivo analysis of granulomonocytic cell

Byrne R, Rath E, Hladik A, Niederreiter B, Bonelli M, Frantal S, Smolen JS, Scheinecker C. PLoS One. 2012;7(4):e35194.

Vascular smooth muscle Jak2 deletion prevents angiotensin II-mediated neointima - Vascular smooth muscle Jak2 deletion prevents angiotensin II-mediated neointima

Kirabo A, Oh SP, Kasahara H, Wagner KU, Sayeski PP. J Mol Cell Cardiol. 2011 Jun;50(6):1026-34.